Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Trasplante Autólogo de Médula Ósea (TAMO) is a specialized medical center located in Puebla, Mexico, operating as a core division of Clínica Ruiz. The center is internationally recognized for its pioneering work in hematopoietic stem cell transplantation, specifically for the treatment of autoimmune diseases like multiple sclerosis and hematological cancers such as multiple myeloma. TAMO is the developer of the "Mexican Method," a simplified, outpatient-based autologous transplant protocol that significantly reduces costs and hospitalization time while maintaining high safety standards. This innovative approach has made the facility a global destination for patients seeking affordable and effective cellular therapies. Led by Dr. Guillermo Ruiz-Argüelles, the center integrates clinical care with robust academic research and has performed thousands of transplants for patients from around the world.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Trasplante Autólogo de Médula Ósea.